SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: StockDung who wrote (14947)4/6/2005 7:27:11 PM
From: SEC-ond-chance  Respond to of 19428
 
Here you go, I never noticed this before. Dr. Lin got an "enhanced sentence" because of violating a prior injunction. But this was only cause there was a simultaneous criminal proceeding (money laundering, etc). So an enhanced sentence for SEC recividists if you are unlucky enough to get a criminal conviction by another governmental agency.

SECURITIES LAW RECIDIVIST SENTENCED TO OVER 5 YEARS IN PRISON

On April 22, the U.S. District Court for the Eastern District of New York sentenced Dr. Jui-Teng Lin to 5 years and 10 months in prison for securities fraud and money laundering. Dr. Lin was convicted by jury trial on Dec. 13, 2002. According to the evidence at trial, Dr. Lin manipulated the common stock of Surgilight, Inc., a publicly traded company headquartered in Orlando, Florida. Dr. Lin settled a prior civil action brought by the Commission in 1998 by consenting to a permanent injunction against further violations of the federal securities laws [see SEC v. Jui-Teng Lin and Yuchin Lin, Litigation Release No. 15870 (Sept. 3, 1998)]. Dr. Lin's violation of that injunction resulted in an enhancement of his sentence in the Surgilight case. Simultaneously with his indictment, the Commission filed a civil action against Dr. Lin and others in the U.S. District Court for the Middle District of Florida arising out of the same securities fraud for which he was convicted. That action is pending. For further information, see Litigation Release Nos. 17899 (Dec. 17, 2002) and 17469 (April 11, 2002). [U.S. v. Jui-Teng Lin, CR-02-0423, DGT, EDNY] (LR- 18099)